戻る Agenda
S02 : Advancing Pharmacovigilance: ICSR Management, RWE Usage, and Their Combined Value for Patient Safety
Session Chair(s)
Osamu Ida
Regional Head, Patient Safety QA Japan, Novartis Pharma K. K., Japan
Speaker(s)
Sam Wallis
, Bristol-Myers Squibb, United States
Sarah Vaughan
Head of Vigilance Operations, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Rieko Saito
Deputy Division Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Hirotami Ohara
Country Safety Head Japan, Local Medical Safety, Innovative Medicine, Johnson & Johnson, Japan
Koji Kawamura
Head of Pharmacovigilance Department 2, Pharmacovigilance, CMIC Co., Ltd., Japan